RXRX · Biotech
Recursion Pharmaceuticals
AI-driven drug discovery platform combining machine learning with biology automation.
Price
…$5.95
+1.80% today
AI Opportunity Score
60 / 100
Estimate, not a recommendation.
Risk for beginners
Higher
Industry
Biotech
Emerging growth theme
Price trend · Recursion Pharmaceuticals
Educational only · Past performance does not guarantee future results.
AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.
Why investors are watching this
- Nvidia investment and partnership
- Merger with Exscientia consolidates AI biotech
- Multiple pipeline programs in trials
Why this could grow
- AI could compress drug discovery timelines
- Pharma partnerships fund the platform
- Massive proprietary biological dataset
What could go wrong
- AI-discovered drugs still need to prove themselves clinically
- High cash burn
- Competition from big pharma in-house AI
Ground floor potential
Why it may still be early
AI-driven drug R&D is early innings industry-wide.
How the industry may expand
Pharma R&D spend over $250B per year.
Compared to larger competitors
Differentiated platform play vs traditional biotech.
Why this passed our AI quality filter
- Strategic backing from Nvidia
- Multiple programs in clinical trials
- Real pharma partnership revenue
📤 Smart Exit Guidance
Mixed exit signals
No urgent signals either way — a calm moment to reflect on your goals.
High-volatility phase
Worth monitoringWhy: Volatility for Recursion Pharmaceuticals is elevated (80/100), so swings in either direction may be larger than usual.
What changed: Daily price ranges have widened.
When investors sometimes consider selling
- When volatility is elevated, some investors reduce position size to sleep better at night.
- Reaching a personal goal (down payment, life milestone) is a common reason people take some profits regardless of price action.
- Diversification matters — if a single position grows to dominate the portfolio, some investors rebalance.
Rebound potential analysis
Possible rebound factors — these are estimates, not guarantees.
Temporary volatility
Volatile periods can see quick reversals in either direction. Reactions tend to fade faster than fundamentals shift.
Rebound timing and magnitude are uncertain. Markets can stay weak longer than expected.
Long-term scenario calculator
Estimate possible outcomes across different time horizons. AI-generated estimates only — actual market performance may vary significantly.
Investment amount
$500
After 6 mo
Conservative
$403.11
Expected
$591.61
Bullish
$866.03
After 1 yr
Conservative
$325.00
Expected
$700.00
Bullish
$1500.00
After 3 yr
Conservative
$137.31
Expected
$1372.00
Bullish
$13500.00
After 5 yr
Conservative
$58.01
Expected
$2689.12
Bullish
$121500.00
AI-generated estimates only. Not financial advice. Market conditions can change and no outcome is guaranteed.
About this AI estimate
- AI-generated estimate — not a prediction or guarantee.
- Educational use only.
- Market conditions can change rapidly.
- Outcomes may vary significantly from any projection shown.
Where can I buy this?
Availability across popular investing platforms. Always confirm fees and limits in the app you choose.
- Fractional
Robinhood
Commission-free fractional shares
- Fractional
Crypto.com
Buy & sell instantly — funds stay in your wallet
- Fractional
Fidelity Investments
Fractional shares from $1
- Fractional
Charles Schwab
Stock Slices from $5
- Fractional
Webull
Educational availability info — not a recommendation of any broker.
Legal disclaimer
- InvestMike uses AI-generated analysis and estimates that may contain inaccuracies or errors.
- InvestMike is for informational and educational purposes only and does not provide financial advice.
- All investing involves risk, including possible loss of money.
- Users are solely responsible for their investment decisions.
- Past performance does not guarantee future results.
- AI-generated predictions are estimates only and should not be treated as guarantees.
- InvestMike and its creators are not responsible for financial losses resulting from investment decisions.